India's Active caseload declines to 32,811 today; stands at 0.08% of India’s total positive cases.
Following a continuous downward trend, India’s active caseload has declined to 32,811 today. Active cases constitute 0.08% of the country's total positive cases. Consequently, India’s recovery rate stands at 98.72%. 3,884 patients have recovered in the last 24 hours, and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at […]
Mechanism to prevent violence against doctors
As per Constitutional provisions, ‘Health’ and ‘Law & Order’ are State subjects. State Governments are expected to set up mechanisms to prevent violence against doctors including imposition of penalties or setting up Helplines to extend immediate help to such Doctors who are victims of violence. Details of number of instances of attacks on doctors are […]
Benefits of CoWIN Portal
The CoWIN Portal is the digital platform to capture COVID-19 vaccination program details. CoWIN connects to various stakeholders, including vaccine manufacturers, administrators, and verifiers; public and private vaccination facilities; vaccine recipients, etc. The key features of the CoWIN platform are The CoWIN platform was developed in a record speed with ample consideration to its scalability, […]
COVID-19 Vaccination for 12-14 yrs cohort to begin from tomorrow, National Vaccination Day, in all states/UTs.
Free of cost COVID-19 vaccination for all beneficiaries of the 12-14 age group will begin tomorrow (16th March 2022), National Vaccination Day, at all government COVID vaccination centers. The COVID-19 vaccine to be administered would be Corbevax, manufactured by Biological E. Limited, Hyderabad. This can be through online registration (beginning 9 am on 16th March […]
Vaccine vial monitoring
Studies at various ambient temperature and duration are required to finalize when the vaccine reaches end point beyond which it cannot be used to decide the type of Vaccine Vial Monitoring (VVM) to be used. VVM is manufactured by a single offshore manufacturer and in view of the global urgency to use COVID-19 vaccine upon […]
WHO is working day and night to keep medical supply chains open and preserve Ukraine’s health system
14 March 2022 / Ukraine -- Since Russia’s military offensive began in Ukraine on 24 February, WHO has worked around the clock to ensure a constant flow of health supplies so that neighbouring countries have the infrastructure and expertise to meet urgent needs of refugees, and to support Ukraine’s health system to meet the immediate […]
The Department of Pharmaceuticals extends the date of receipt of applications for the vacant slots under Production Linked Incentive (PLI) scheme for Bulk Drugs till the end of March 2022 from the previous deadline of 13.03.2022
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers has extended the date of receipt of applications for the vacant slots under “Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country” shortly called as PLI scheme for Bulk Drugs […]
Stop attacks on health care in ukraine
13 March 2022 -- Geneva / New York -- “Today, we call for an immediate cessation of all attacks on health care in Ukraine. These horrific attacks are killing and causing serious injuries to patients and health workers, destroying vital health infrastructure and forcing thousands to forgo accessing health services despite catastrophic needs. "To attack […]
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases Approach paper on 'Draft National Medical Devices Policy 2022' for consultation
The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers has released on its website, an Approach Paper for the Draft National Policy for the Medical Devices, 2022, inviting feedback and remarks of the Industry and stakeholders, till the 25th of March 2022. In line with the mandate of promoting aspects of the medical device […]
FDA Advisory Committee votes in favour of the clinical benefit of Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma
U.S. FDA’s Oncologic Drugs Advisory Committee voted 11 to 2 in favour of the clinical benefit of the phase III POLARIX study of Polivy in combination with R-CHP for people with previously untreated diffuse large B-cell lymphoma (DLBCL) This is the first treatment in 20 years to show a significant and clinically meaningful improvement in […]
